Skip to main content

Opioid Addiction

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Aphios
AphiosMA - Woburn
1 program
1
APH-1501Phase 21 trial
Active Trials
NCT03813095Unknown32Est. Dec 2025
Pins Medical
Pins MedicalChina - Beijing
1 program
1
Deep brain stimulation:PINS Stimulation SystemPhase 11 trial
Active Trials
NCT02282072Unknown20Est. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AphiosAPH-1501
Pins MedicalDeep brain stimulation:PINS Stimulation System

Clinical Trials (2)

Total enrollment: 52 patients across 2 trials

Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction

Start: Oct 2023Est. completion: Dec 202532 patients
Phase 2Unknown
NCT02282072Pins MedicalDeep brain stimulation:PINS Stimulation System

PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction

Start: Dec 2016Est. completion: Dec 201820 patients
Phase 1Unknown

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.